Biliary Atresia: A Case Report

Maliha Muzaffer1, Anees Masarath1, Fareedullah Mohammed1

  • 1Department of Pharmacy, Mesco College of Pharmacy, Hyderabad, IND.

Cureus
|January 6, 2025
PubMed

Insights

Biliary atresia (BA) is a severe infant liver disease. Liver transplantation offers a definitive solution for infants with BA who experience Kasai procedure failure.

Area of Science:

  • Pediatric Hepatology
  • Surgical Gastroenterology
  • Infant Liver Disease

Background:

  • Biliary atresia (BA) is a life-threatening infant hepatobiliary disorder.
  • Early diagnosis and intervention are crucial for improving prognosis in BA.
  • Untreated BA leads to liver damage and mortality.

Observation:

  • A 9-month-old infant presented with jaundice, acholic feces, and hepatomegaly.
  • Diagnostic tests including elevated liver enzymes and HIDA scan confirmed BA.
  • Histopathology showed fibrosis, cholestasis, and an atretic gallbladder.

Findings:

  • A modified Kasai portoenterostomy (KPE) was performed, but the infant showed persistent jaundice and liver dysfunction.
  • The Kasai procedure ultimately failed, indicating end-stage liver disease.
  • Liver transplantation (LT) was deemed the necessary definitive treatment.

Implications:

  • Liver transplantation is effective for treating BA cases with failed Kasai procedures.
  • This case underscores the potential for improved outcomes with LT in infants with end-stage BA.
  • Timely LT can significantly enhance the prognosis for infants with severe biliary atresia.